tiprankstipranks
Trending News
More News >
Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs
PremiumCompany AnnouncementsImmatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs
1M ago
Immatics reports Q1 EPS (EUR 0.33) vs (EUR 0.03) last year
Premium
The Fly
Immatics reports Q1 EPS (EUR 0.33) vs (EUR 0.03) last year
1M ago
Immatics: Strong Buy Rating Backed by Pipeline Progress and Financial Stability
Premium
Ratings
Immatics: Strong Buy Rating Backed by Pipeline Progress and Financial Stability
3M ago
Immatics Advances PRAME Cell Therapy and Expands Oncology Pipeline
PremiumCompany AnnouncementsImmatics Advances PRAME Cell Therapy and Expands Oncology Pipeline
5M ago
Immatics price target lowered to $13 from $15 at BofA
Premium
The Fly
Immatics price target lowered to $13 from $15 at BofA
5M ago
Immatics Faces Termination of Key Collaboration with Bristol Myers Squibb
Premium
Company Announcements
Immatics Faces Termination of Key Collaboration with Bristol Myers Squibb
6M ago
Immatics announces clinical data on TCER IMA402 targeting PRAME
PremiumThe FlyImmatics announces clinical data on TCER IMA402 targeting PRAME
7M ago
Immatics Sees Revenue Surge Despite R&D Expenses
Premium
Company Announcements
Immatics Sees Revenue Surge Despite R&D Expenses
7M ago
Immatics sees cash runway into 2H27
Premium
The Fly
Immatics sees cash runway into 2H27
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100